Behavioral profiling of zebrafish embryos exposed to a panel of 60 water-soluble compounds

Behavioural Brain Research

Volumn 228, Issue 2, 2012, Pages 272-283

  Ali, Shaukat ^a   Champagne, Danielle L ^a,b   Richardson, Michael K ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Behavior; Drug discovery; Predictive model; Safety pharmacology; Toxicology; Zebrafish embryo

Indexed keywords

ACETIC ACID; ACONITINE; ALCOHOL; ALKALOID; AMITRIPTYLINE; AMPICILLIN; ARBUTIN; ATROPINE; AURANTIIN; BARBITAL; BERBERINE CHLORIDE; COLCHICINE; DIGITOXIN; DODECYL SULFATE SODIUM; FORMALDEHYDE; GLYCEROL; HESPERIDIN; ISONIAZID; MORPHINE; NICOTINE; PARACETAMOL; PHENACETIN; PHENOL; QUININE SULFATE; SALICYLIC ACID; SODIUM AZIDE; THEOBROMINE; TOXIC SUBSTANCE; TOXIN; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; FUNCTIONAL DISEASE; LARVA; LC 50; LOCOMOTION; MALE; NEUROTOXICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STIMULUS RESPONSE; TOXICITY TESTING; VISUOMOTOR COORDINATION; ZEBRA FISH;

ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; DRUG TOXICITY; EMBRYO, NONMAMMALIAN; FEMALE; LETHAL DOSE 50; MALE; MODELS, ANIMAL; MOTOR ACTIVITY; TIME FACTORS; TOXICITY TESTS; ZEBRAFISH;

EID: 84856224090     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.11.020     Document Type: Article

References (87)

1. Agid Y., Buzsaki G., Diamond D.M., Frackowiak R., Giedd J., Girault J.A., et al. How can drug discovery for psychiatric disorders be improved. Nat Rev Drug Discov 2007, 6:189-201.
2. Craven R. The risky business of drug development in neurology. Lancet Neurol 2011, 10:116-117.
3. Ali S., van Mil H.G., Richardson M.K. Large-scale assessment of the zebrafish embryo as a possible predictive model in toxicity testing. PLoS ONE 2011, 6:e21076.
4. Lieschke G.J., Currie P.D. Animal models of human disease: zebrafish swim into view. Nat Rev Genet 2007, 8:353-367.
5. Hill A.J., Teraoka H., Heideman W., Peterson R.E. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 2005, 86:6-19.
6. Milan D.J., Peterson T.A., Ruskin J.N., Peterson R.T., Macrae C.A. Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 2003, 107:1355-1358.
7. Parng C., Seng W.L., Semino C., McGrath P. Zebrafish: a preclinical model for drug screening. Assay Drug Dev Technol 2002, 1:41-48.
8. Rihel J., Prober D.A., Arvanites A., Lam K., Zimmerman S., Jang S., et al. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 2010, 327:348-351.
9. Brannen K.C., Panzica-Kelly J.M., Danberry T.L., Augustine-Rauch K.A. Development of a zebrafish embryo teratogenicity assay and quantitative prediction model. Birth Defects Res B: Dev Reprod Toxicol 2010, 89:66-77.
10. Selderslaghs IW, Blust R, Witters HE. Feasibility study of the zebrafish assay as an alternative method to screen for developmental toxicity and embryotoxicity using a training set of 27 compounds. Reprod Toxicol, doi:10.1016/j.reprotox.2011.08.003.
11. Redfern W.S., Waldron G., Winter M.J., Butler P., Holbrook M., Wallis R., et al. Zebrafish assays as early safety pharmacology screens: paradigm shift or red herring. J Pharmacol Toxicol Methods 2008, 58:110-117.
12. Ali S., Champagne D.L., Spaink H.P., Richardson M.K. Zebrafish embryos and larvae: a new generation of disease models and drug screens. Birth Defects Res C: Embryo Today 2011, 93:115-133.
13. Rubinstein A.L. Zebrafish: from disease modeling to drug discovery. Curr Opin Drug Discov Devel 2003, 6:218-223.
14. Kimmel C.B., Ballard W.W., Kimmel S.R., Ullmann B., Schilling T.F. Stages of embryonic development of the zebrafish. Dev Dyn 1995, 203:253-310.
15. Voelker D., Vess C., Tillmann M., Nagel R., Otto G.W., Geisler R., et al. Differential gene expression as a toxicant-sensitive endpoint in zebrafish embryos and larvae. Aquat Toxicol 2007, 81:355-364.
16. Brittijn S.A., Duivesteijn S.J., Belmamoune M., Bertens L.F., Bitter W., de Bruijn J.D., et al. Zebrafish development and regeneration: new tools for biomedical research. Int J Dev Biol 2009, 53:835-850.
17. Teraoka H., Dong W., Hiraga T. Zebrafish as a novel experimental model for developmental toxicology. Congenit Anom (Kyoto) 2003, 43:123-132.
18. Labrot F., Narbonne J.F., Ville P., Saint D.M., Ribera D. Acute toxicity, toxicokinetics, and tissue target of lead and uranium in the clam Corbicula fluminea and the worm Eisenia fetida: comparison with the fish Brachydanio rerio. Arch Environ Contam Toxicol 1999, 36:167-178.
19. Kumar K., Ansari B.A. Malathion toxicity: effect on the liver of the fish Brachydanio rerio (Cyprinidae). Ecotoxicol Environ Saf 1986, 12:199-205.
20. Roche H., Boge G., Peres G. Acute and chronic toxicities of colchicine in Brachydanio rerio. Bull Environ Contam Toxicol 1994, 52:69-73.
21. Zok S., Gorge G., Kalsch W., Nagel R. Bioconcentration, metabolism and toxicity of substituted anilines in the zebrafish (Brachydanio rerio). Sci Total Environ 1991, 109-110:411-421.
22. Lanzky P.F., Halling-Sorensen B. The toxic effect of the antibiotic metronidazole on aquatic organisms. Chemosphere 1997, 35:2553-2561.
23. Gorge G., Nagel R. Toxicity of lindane, atrazine, and deltamethrin to early life stages of zebrafish (Brachydanio rerio). Ecotoxicol Environ Saf 1990, 20:246-255.
24. Truong L., Harper S.L., Tanguay R.L. Evaluation of embryotoxicity using the zebrafish model. Methods Mol Biol 2011, 691:271-279.
25. George S., Xia T., Rallo R., Zhao Y., Ji Z., Lin S., et al. Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials. ACS Nano 2011, 5:1805-1817.
26. Bai W., Tian W., Zhang Z., He X., Ma Y., Liu N., et al. Effects of copper nanoparticles on the development of zebrafish embryos. J Nanosci Nanotechnol 2010, 10:8670-8676.
27. Ali S., Champagne D.L., Alia A., Richardson M.K. Large-scale analysis of acute ethanol exposure in zebrafish development: a critical time window and resilience. PLoS ONE 2011, 6:e20037.
28. Sylvain N.J., Brewster D.L., Ali D.W. Zebrafish embryos exposed to alcohol undergo abnormal development of motor neurons and muscle fibers. Neurotoxicol Teratol 2010, 32:472-480.
29. Scholz S., Fischer S., Gundel U., Kuster E., Luckenbach T., Voelker D., et al. The zebrafish embryo model in environmental risk assessment-applications beyond acute toxicity testing. Environ Sci Pollut Res Int 2008, 15:394-404.
30. Champagne D.L., Hoefnagels C.C., de Kloet R.E., Richardson M.K. Translating rodent behavioral repertoire to zebrafish (Danio rerio): relevance for stress research. Behav Brain Res 2010, 214:332-342.
31. Burne T., Scott E., van S.B., Hilliard M., Reinhard J., Claudianos C., et al. Big ideas for small brains: what can psychiatry learn from worms, flies, bees and fish. Mol Psychiatry 2011, 16:7-16.
32. Guo S. Using zebrafish to assess the impact of drugs on neural development and function. Expert Opin Drug Discov 2009, 4:715-726.
33. Guo S. Linking genes to brain, behavior and neurological diseases: what can we learn from zebrafish. Genes Brain Behav 2004, 3:63-74.
34. Morris J.A. Zebrafish: a model system to examine the neurodevelopmental basis of schizophrenia. Prog Brain Res 2009, 179:97-106.
35. Pogoda H.M., Hammerschmidt M. How to make a teleost adenohypophysis: molecular pathways of pituitary development in zebrafish. Mol Cell Endocrinol 2009, 312:2-13.
36. Postlethwait J.H., Woods I.G., Ngo-Hazelett P., Yan Y.L., Kelly P.D., Chu F., et al. Zebrafish comparative genomics and the origins of vertebrate chromosomes. Genome Res 2000, 10:1890-1902.
37. Rodriguez F., Lopez J.C., Vargas J.P., Broglio C., Gomez Y., Salas C., et al. Spatial memory and hippocampal pallium through vertebrate evolution: insights from reptiles and teleost fish. Brain Res Bull 2002, 57:499-503.
38. Schaaf M.J., Champagne D., van Laanen I.H., van Wijk D.C., Meijer A.H., Meijer O.C., et al. Discovery of a functional glucocorticoid receptor beta-isoform in zebrafish. Endocrinology 2008, 149:1591-1599.
39. Sison M., Cawker J., Buske C., Gerlai R. Fishing for genes influencing vertebrate behavior: zebrafish making headway. Lab Anim (NY) 2006, 35:33-39.
40. Tropepe V., Sive H.L. Can zebrafish be used as a model to study the neurodevelopmental causes of autism. Genes Brain Behav 2003, 2:268-281.
41. Veldman M.B., Lin S. Zebrafish as a developmental model organism for pediatric research. Pediatr Res 2008, 64:470-476.
42. Steenbergen P.J., Richardson M.K., Champagne D.L. The use of the zebrafish model in stress research. Prog Neuropsychopharmacol Biol Psychiatry 2010, 35:1432-1451.
43. Brustein E., Saint-Amant L., Buss R.R., Chong M., McDearmid J.R., Drapeau P., et al. Steps during the development of the zebrafish locomotor network. J Physiol Paris 2003, 97:77-86.
44. Drapeau P., Saint-Amant L., Buss R.R., Chong M., McDearmid J.R., Brustein E., et al. Development of the locomotor network in zebrafish. Prog Neurobiol 2002, 68:85-111.
45. McLean D.L., Fetcho J.R. Ontogeny and innervation patterns of dopaminergic, noradrenergic, and serotonergic neurons in larval zebrafish. J Comp Neurol 2004, 480:38-56.
46. Wullimann M.F., Mueller T. Teleostean and mammalian forebrains contrasted: evidence from genes to behavior. J Comp Neurol 2004, 475:143-162.
47. Panula P., Chen Y.C., Priyadarshini M., Kudo H., Semenova S., Sundvik M., et al. The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases. Neurobiol Dis 2010, 40:46-57.
48. Kaslin J., Panula P. Comparative anatomy of the histaminergic and other aminergic systems in zebrafish (Danio rerio). J Comp Neurol 2001, 440:342-377.
49. Parker B., Connaughton V.P. Effects of nicotine on growth and development in larval zebrafish. Zebrafish 2007, 4:59-68.
50. Kokel D., Bryan J., Laggner C., White R., Cheung C.Y., Mateus R., et al. Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol 2010, 6:231-237.
51. Kokel D., Peterson R.T. Using the zebrafish photomotor response for psychotropic drug screening. Methods Cell Biol 2011, 105:517-524.
52. Dahm R., Geisler R. Learning from small fry: the zebrafish as a genetic model organism for aquaculture fish species. Mar Biotechnol (NY) 2006, 8:329-345.
53. Grunwald D.J., Eisen J.S. Headwaters of the zebrafish-emergence of a new model vertebrate. Nat Rev Genet 2002, 3:717-724.
54. Hu N., Yost H.J., Clark E.B. Cardiac morphology and blood pressure in the adult zebrafish. Anat Rec 2001, 264:1-12.
55. Peterson K.J., Lyons J.B., Nowak K.S., Takacs C.M., Wargo M.J., McPeek M.A., et al. Estimating metazoan divergence times with a molecular clock. Proc Natl Acad Sci USA 2004, 101:6536-6541.
56. Lee K.J., Nallathamby P.D., Browning L.M., Osgood C.J., Xu X.H. In vivo imaging of transport and biocompatibility of single silver nanoparticles in early development of zebrafish embryos. ACS Nano 2007, 1:133-143.
57. Henn K., Braunbeck T. Dechorionation as a tool to improve the fish embryo toxicity test (FET) with the zebrafish (Danio rerio). Comp Biochem Physiol C: Toxicol Pharmacol 2011, 153:91-98.
58. McGrath P., Li C.Q. Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discov Today 2008, 13:394-401.
59. Kokel D., Peterson R.T. Chemobehavioural phenomics and behaviour-based psychiatric drug discovery in the zebrafish. Brief Funct Genomic Proteomic 2008, 7:483-490.
60. Wielhouwer E.M., Ali S., Al-Afandi A., Blom M.T., Olde Riekerink M.B., et al. Zebrafish embryo development in a microfluidic flow-through system. Lab Chip 2011, 11:1815-1824.
61. Fraysse B., Mons R., Garric J. Development of a zebrafish 4-day embryo-larval bioassay to assess toxicity of chemicals. Ecotoxicol Environ Saf 2006, 63:253-267.
62. United States Environmental Protection Agency Ecological Effects Test Guidelines: OPPTS 850.1075: Fish Acute Toxicity Test, Freshwater and Marine; 1996, p. 1-11.
63. Burgess H.A., Granato M. Modulation of locomotor activity in larval zebrafish during light adaptation. J Exp Biol 2007, 210:2526-2539.
64. Emran F., Rihel J., Dowling J.E. A behavioral assay to measure responsiveness of zebrafish to changes in light intensities. J Vis Exp 2008, 3. 10.3791/923.
65. Macphail R.C., Brooks J., Hunter D.L., Padnos B., Irons T.D., Padilla S., et al. Locomotion in larval zebrafish: influence of time of day, lighting and ethanol. Neurotoxicology 2009, 30:52-58.
66. Irons T.D., Macphail R.C., Hunter D.L., Padilla S. Acute neuroactive drug exposures alter locomotor activity in larval zebrafish. Neurotoxicol Teratol 2010, 32:84-90.
67. Chan T.Y. Aconite poisoning. Clin Toxicol (Phila) 2009, 47:279-285.
68. al A.O., Bevan D.R. Clindamycin-induced neuromuscular blockade. Can J Anaesth 1995, 42:614-617.
69. Grynkiewicz G., Gadzikowska M. Tropane alkaloids as medicinally useful natural products and their synthetic derivatives as new drugs. Pharmacol Rep 2008, 60:439-463.
70. Svoboda K.R., Vijayaraghavan S., Tanguay R.L. Nicotinic receptors mediate changes in spinal motoneuron development and axonal pathfinding in embryonic zebrafish exposed to nicotine. J Neurosci 2002, 22:10731-10741.
71. Macphail R.C., Farmer J.D., Jarema K.A. Effects of acute and weekly episodic exposures to anatoxin-a on the motor activity of rats: comparison with nicotine. Toxicology 2007, 234:83-89.
72. Makarovsky I., Markel G., Hoffman A., Schein O., Brosh-Nissimov T., Tashma Z., et al. Strychnine-a killer from the past. Isr Med Assoc J 2008, 10:142-145.
73. Airavaara M., Tuomainen H., Piepponen T.P., Saarma M., Ahtee L. Effects of repeated morphine on locomotion, place preference and dopamine in heterozygous glial cell line-derived neurotrophic factor knockout mice. Genes Brain Behav 2007, 6:287-298.
74. Addicott M.A., Marsh-Richard D.M., Mathias C.W., Dougherty D.M. The biphasic effects of alcohol: comparisons of subjective and objective measures of stimulation, sedation, and physical activity. Alcohol Clin Exp Res 2007, 31:1883-1890.
75. Gerlai R., Lahav M., Guo S., Rosenthal A. Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects. Pharmacol Biochem Behav 2000, 67:773-782.
76. Correa M., Roig-Navarro A.F., Aragon C.M. Motor behavior and brain enzymatic changes after acute lead intoxication on different strains of mice. Life Sci 2004, 74:2009-2021.
77. Kashyap B., Frederickson L.C., Stenkamp D.L. Mechanisms for persistent microphthalmia following ethanol exposure during retinal neurogenesis in zebrafish embryos. Vis Neurosci 2007, 24:409-421.
78. Stehr C.M., Linbo T.L., Incardona J.P., Scholz N.L. The developmental neurotoxicity of fipronil: notochord degeneration and locomotor defects in zebrafish embryos and larvae. Toxicol Sci 2006, 92:270-278.
79. Souza B.R., Romano-Silva M.A., Tropepe V. Dopamine D2 receptor activity modulates Akt signaling and alters GABAergic neuron development and motor behavior in zebrafish larvae. J Neurosci 2011, 31:5512-5525.
80. Sylvain N.J., Brewster D.L., Ali D.W. Embryonic ethanol exposure alters synaptic properties at zebrafish neuromuscular junctions. Neurotoxicol Teratol 2011, 33:313-321.
81. Li P., Shah S., Huang L., Carr A.L., Gao Y., Thisse B., et al. Cloning and spatial and temporal expression of the zebrafish dopamine D1 receptor. Dev Dyn 2007, 236:1339-1346.
82. Sanchez-Simon F.M., Rodriguez R.E. Developmental expression and distribution of opioid receptors in zebrafish. Neuroscience 2008, 151:129-137.
83. Arihan O., Boz M., Iskit A.B., Ilhan M. Antinociceptive activity of coniine in mice. J Ethnopharmacol 2009, 125:274-278.
84. Zirger J.M., Beattie C.E., McKay D.B., Boyd R.T. Cloning and expression of zebrafish neuronal nicotinic acetylcholine receptors. Gene Expr Patterns 2003, 3:747-754.
85. Klee E.W., Ebbert J.O., Schneider H., Hurt R.D., Ekker S.C. Zebrafish for the study of the biological effects of nicotine. Nicotine Tob Res 2011, 13:301-312.
86. Postlethwait J., Amores A., Cresko W., Singer A., Yan Y.L. Subfunction partitioning, the teleost radiation and the annotation of the human genome. Trends Genet 2004, 20:481-490.
87. Sipos M.L., Burchnell V., Galbicka G. Dose-response curves and time-course effects of selected anticholinergics on locomotor activity in rats. Psychopharmacology (Berl) 1999, 147:250-256.